Results for tag: "Biomarker Partnering"

Biomarker Partnering is a market that focuses on the development and commercialization of biomarkers. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. Biomarker Partnering involves the collaboration between pharmaceutical companies, biotechnology companies, and academic institutions to develop and commercialize biomarkers. This market is driven by the need for more accurate and reliable diagnostic tests, as well as the need for more personalized treatments. Companies in the Biomarker Partnering market include Roche, Novartis, Merck, Pfizer, AstraZeneca, and Johnson & Johnson. These companies are actively involved in the development and commercialization of biomarkers, and are working to develop new and innovative diagnostic tests and treatments. Show Less Read more